NCT06178445 2026-03-27
TRAP-BTC
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Phase 2 Active not recruiting
Clinical Trials
15 trialsNCT05994001 2026-02-18
Candonilimab in Combination With LM-302 for Claudin 18.2 Positive-advanced Biliary Tract Cancer After Failure of Standard of Chemotherapy and PD1/PD-L1 Antibody
Shanghai Zhongshan Hospital
Phase 1/2 Active not recruiting
NCT04005339 2026-01-26
NAPOLI-2: Fluorouracil, Leucovorin, and Nanoliposomal Irinotecan in Biliary Cancer
Georgetown University
Phase 2 Active not recruiting
NCT05036486 2026-01-20
The Registry of Genetic Alterations of Taiwan Biliary Tract Cancer
National Health Research Institutes, Taiwan
Active not recruiting
NCT05170438 2026-01-20
LenPac
National Health Research Institutes, Taiwan
Phase 2 Active not recruiting
NCT05220046 2025-12-17
Palliadelic Treatment to Reduce Psychological Distress in Persons With Advanced Gastrointestinal Cancers
University of Nebraska
Phase 1 Active not recruiting
NCT05297903 2025-09-15
XmAb20717 in Advanced Biliary Tract Cancers
Abramson Cancer Center at Penn Medicine
Phase 2 Active not recruiting
NCT06975917 2025-05-16
TOG-SAFRADJU
Ankara University
Active not recruiting
NCT02908048 2025-04-06
Extracellular RNA Markers of Liver Disease and Cancer
Mayo Clinic
Active not recruiting
NCT03631173 2025-03-25
MINIMUM
Oslo University Hospital
Phase NA Active not recruiting
NCT03695952 2025-01-28
A Prospective Cohort Study of Patients with Hepatobiliary Cancer Treated with Immune Checkpoint Inhibitors
Asan Medical Center
Active not recruiting
NCT04308174 2025-01-28
DEBATE
Asan Medical Center
Phase 2 Active not recruiting
NCT04584008 2024-10-15
VISIONARY
Peking University
Phase NA Active not recruiting
NCT06490107 2024-07-08
Durvalumab Combined With S-1 as Adjuvant Therapy of Resectable BTC
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Active not recruiting
NCT03046862 2024-04-19
Durvalumab(MEDI4736)/Tremelimumab in Combination With Gemcitabine/Cisplatin in Chemotherapy-naïve Biliary Tract Cancer
Seoul National University Hospital
Phase 2 Active not recruiting